EFFICIENT STEM CELL MOBILIZATION IN LENALIDOMIDE TREATED MULTIPLE MYELOMA PATIENTS CAN BE ACHIEVED BY MOBILIZATION WITH DCEP (DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATINUM) FOLLOWED BY HIGH-DOSE G-CSF

被引:0
|
作者
Badin, S. M. [1 ]
Lendvai, N. [2 ]
Gounder, S. K. [1 ]
Rowley, S. [2 ]
Donato, M. [2 ]
Goldberg, S. [2 ]
Pecora, A. [2 ]
McBride, L. H. [2 ]
Schmidt, L. [2 ]
Donadio, K. A. [2 ]
McNeil, A. [2 ]
Siegel, D. S. [2 ]
机构
[1] UMDNJ, Newark, NJ USA
[2] HUMC, Hackensack, NJ USA
关键词
D O I
10.1016/j.bbmt.2007.12.194
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
185
引用
收藏
页码:68 / 68
页数:1
相关论文
共 50 条
  • [31] Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma
    S Bilgrami
    RD Bona
    RL Edwards
    Z Li
    B Naqvi
    A Shaikh
    F Furlong
    J Fox
    J Clive
    PJ Tutschka
    Bone Marrow Transplantation, 2001, 28 : 137 - 143
  • [32] A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma
    R Silvennoinen
    P Anttila
    M Säily
    T Lundan
    J Heiskanen
    T M Siitonen
    S Kakko
    M Putkonen
    H Ollikainen
    V Terävä
    A Kutila
    K Launonen
    A Räsänen
    A Sikiö
    M Suominen
    P Bazia
    K Kananen
    T Selander
    T Kuittinen
    K Remes
    E Jantunen
    Bone Marrow Transplantation, 2016, 51 : 372 - 376
  • [33] Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization
    Gazitt, Y
    Freytes, CO
    Callander, N
    Tsai, TW
    Alsina, M
    Anderson, J
    Holle, L
    Cruz, J
    Devoer, P
    McGrath, M
    West, G
    Alvarez, R
    Montgomery, W
    JOURNAL OF HEMATOTHERAPY, 1999, 8 (02): : 173 - 183
  • [34] STEM CELL MOBILIZATION EFFICIENCY OF HIGH DOSE CYCLOPHOSPHAMIDE COMPARED TO INTERMEDIATE DOSE CYCLOPHOSPHAMIDE IN MULTIPLE MYELOMA PATIENTS
    Colasante, F.
    Schiavo, D.
    Ferreri, A.
    Rinaldi, C.
    Savignano, C.
    Patriarca, F.
    Fanin, R.
    HAEMATOLOGICA, 2017, 102 : 135 - 135
  • [35] Comparison of Peripheral Blood Stem Cell Mobilization with Etoposide or Cyclophosphamide in Patients with Multiple Myeloma
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Lee, Seung-Shin
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    BLOOD, 2017, 130
  • [36] DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients
    Zappasodi, Patrizia
    Nosari, Anna Maria
    Astori, Cesare
    Ciapanna, Dennis
    Bonfichi, Maurizio
    Varettoni, Marzia
    Mangiacavalli, Silvia
    Morra, Enrica
    Lazzarino, Mario
    Corso, Alessandro
    TRANSFUSION, 2008, 48 (05) : 857 - 860
  • [37] COMPARISON OF PERIPHERAL BLOOD STEM CELL (PBSC) MOBILIZATION WITH G-CSF ALONE VS G-CSF WITH CYCLOPHOSPHAMIDE POST VCD INDUCTION IN MULTIPLE MYELOMA
    Chua, C. C.
    Lim, H. Y.
    Chai, K. L.
    Ong, J.
    Sim, S.
    Dickinson, M.
    Campbell, P.
    Hempton, J.
    King, H.
    Dowsing, C.
    Bergin, K.
    Muir, S.
    Gibbs, S.
    Grigg, A.
    HAEMATOLOGICA, 2016, 101 : 541 - 542
  • [38] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    Afifi, S.
    Adel, N. G.
    Devlin, S.
    Duck, E.
    Vanak, J.
    Landau, H.
    Chung, D. J.
    Lendvai, N.
    Lesokhin, A.
    Korde, N.
    Reich, L.
    Landgren, O.
    Giralt, S.
    Hassoun, H.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 546 - 552
  • [39] High-Dose Cyclophosphamide In Combination With G-CSF Versus G-CSF Alone For Mobilization Of Hematopoietic Stem Cells After Induction Therapy Including Velcade, Cyclophosphamide and Dexacort
    Benyamini, Noam
    Avivi, Irit
    Dann, Eldad J.
    Zuckerman, Tsila
    Noa, Lavi
    Katz, Tami
    BLOOD, 2013, 122 (21)
  • [40] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    S Afifi
    N G Adel
    S Devlin
    E Duck
    J Vanak
    H Landau
    D J Chung
    N Lendvai
    A Lesokhin
    N Korde
    L Reich
    O Landgren
    S Giralt
    H Hassoun
    Bone Marrow Transplantation, 2016, 51 : 546 - 552